Skip to main content
. 2018 Nov 24;13:93. doi: 10.1186/s13000-018-0770-4

Fig. 3.

Fig. 3

The comparison of CD8+ and Foxp3+ T cells in residual tumors between pCR and non-pCR patients. There were no significant differences of intratumoral and peritumoral CD8+ cells between pCR and non-pCR cases (a). However, the Foxp3+ T cells, in both intratumoral and peritumoral areas, were significantly lower in pCR patients than in non-pCR (b)